Gaps as a determinant of PARPi response were in part highlighted by the comparison between cells deficient in the hereditary breast and ovarian cancer genes BRCA1 or FANCJ. Cells deficient in either gene display similar defects in HR and fork protection14–16. The gene discussed is BRCA1; the disease is ovarian cancer.